Skip to main content

Table 3 PK parameters of DGX after it was orally administered alone or coadministered with CAM after CPT-11 treatment

From: Digoxin absorption decreased independently of P-gp activity in rats with irinotecan-induced gastrointestinal damage

 

Cmax

AUCpo

MRTpo

MAT

BA

kepo

(ng/mL)

(hr・ng/mL)

(hr)

(hr)

(%)

(1/h)

Control

 DGX alone

6.43 ± 2.75

14.4 ± 3.34

4.09 ± 0.75

2.55 ± 0.80

66.1 ± 11.1

0.187 ± 0.053

 DGX + CAM

19.1 ± 6.39*

22.8 ± 7.73

2.55 ± 0.32*

0.885 ± 0.35*

92.3 ± 11.4*

0.224 ± 0.067

CPT-11

 DGX alone

3.40 ± 2.24

11.3 ± 2.84

5.50 ± 1.44

3.45 ± 1.27

40.8 ± 16.7*

0.166 ± 0.030

 DGX + CAM

5.03 ± 2.86#

13.1 ± 3.27

4.95 ± 1.68#

2.79 ± 1.42#

42.9 ± 15.7#

0.155 ± 0.054

  1. Data are shown as the mean ± SD. (n = 7); *p < 0.05 vs. DGX alone in the control group; #p < 0.05 vs. DGX + CAM in the control group